NMLSFRestart Life Sciences Corp.

About Restart Life Sciences Corp. (NMLSF)

Restart Life Sciences Corp. (NMLSF) is a Biotechnology company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Restart Life Sciences Corp. is a Canadian-based biotechnology company and global leader in psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. Their mission is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder and fragile X syndrome.

Products and services

Psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders.

NMLSF key facts

Ticker symbol

NMLSF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2004

Employees

1

Estimated market cap

$2.82M (as of Apr 10, 2025)

Shares outstanding

33,230,355

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2023)

Restart Life Sciences Corp. leadership

• William Rascan — CEO
• Stephen Glazer — Chief Scientist
• Rebeca Hudson — CFO
• Kelly Young Pladson — Corporate Secretary

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with N